Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects

NCT01365000 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: NKTR118 Formulation 1
DRUG: NKTR118 Formulation 2
DRUG: NKTR118 Formulation 3
DRUG: NKTR118 Formulation 1a
DRUG: NKTR118 Formulation 3a

Sponsor

AstraZeneca